BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24347044)

  • 1. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia.
    Ronchetti D; Tuana G; Rinaldi A; Agnelli L; Cutrona G; Mosca L; Fabris S; Matis S; Colombo M; Gentile M; Recchia AG; Kwee I; Bertoni F; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2014 Mar; 53(3):264-73. PubMed ID: 24347044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Mosca L; Matis S; Fabris S; Lionetti M; Ilariucci F; Zupo S; Musolino C; Levato L; Molica S; Di Raimondo F; Vincelli I; Di Rienzo N; Pesce EA; Angrilli F; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2014 Jul; 89(7):743-50. PubMed ID: 24711230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
    Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
    Kanduri M; Cahill N; Göransson H; Enström C; Ryan F; Isaksson A; Rosenquist R
    Blood; 2010 Jan; 115(2):296-305. PubMed ID: 19897574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
    Morabito F; Cutrona G; Gentile M; Matis S; Todoerti K; Colombo M; Sonaglio C; Fabris S; Reverberi D; Megna M; Spriano M; Lucia E; Rossi E; Callea V; Mazzone C; Festini G; Zupo S; Molica S; Neri A; Ferrarini M
    Br J Haematol; 2009 Jun; 146(1):44-53. PubMed ID: 19438486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of
    Poppova L; Pavlova S; Gonzalez B; Kotaskova J; Plevova K; Dumbovic G; Janovska P; Bystry V; Panovska A; Bezdekova L; Maslejova S; Brychtova Y; Doubek M; Krzyzankova M; Borsky M; Mayer J; Bryja V; Alonso S; Pospisilova S
    Epigenetics; 2022 Dec; 17(12):1628-1635. PubMed ID: 35333703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
    Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia.
    Kaderi MA; Norberg M; Murray F; Merup M; Sundström C; Roos G; Aleskog A; Karlsson K; Axelsson T; Tobin G; Rosenquist R
    Leukemia; 2008 Feb; 22(2):339-43. PubMed ID: 18046447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.
    MacIntyre DA; Jiménez B; Lewintre EJ; Martín CR; Schäfer H; Ballesteros CG; Mayans JR; Spraul M; García-Conde J; Pineda-Lucena A
    Leukemia; 2010 Apr; 24(4):788-97. PubMed ID: 20090781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.